Blog / Specialty

Cardiovascular ASCs and the Office-Based Lab: Economics After the Covered Procedures Expansion

What the CY2026 covered procedures expansion means for cardiovascular case economics in the ASC versus the office-based lab.

A cardiovascular ASC guide to 2026 rule changes, OBL vs ASC economics, implant carve-outs and case costing for cath and EP cases.

Cardiovascular ASCs and the Office-Based Lab: Economics After the Covered Procedures Expansion

Cardiovascular ASC volume is one of the clearest beneficiaries of the CY2026 Medicare rule, which added 560 procedures to the ASC covered procedures list, 271 of them pulled from the phase-out of the inpatient only list (CMS, November 2025). Cardiology sits alongside total joints and spine as a specialty that was inpatient or hospital-only five years ago and is now routine in a well-run center. The payment update that came with the rule, about 2.6 percent for centers that meet quality reporting requirements, is the smallest part of the story. The bigger part is a wave of procedures with no established ASC cost structure and, in many markets, no commercial rate attached yet.

Why cardiovascular cases are moving to ASCs

Site of service economics explain most of the move. Medicare, and the commercial payers that price off Medicare, generally pay less for the same procedure in an ASC than in a hospital outpatient department. Site neutrality is pushing in the same direction: the 2026 rule expanded site-neutral pricing for drug administration services in excepted off-campus hospital departments, paying the physician fee schedule rate instead of the higher hospital rate. The direction for cardiovascular procedures is the same direction orthopedics went a decade ago. For a full breakdown of how ASC and hospital outpatient rates compare procedure by procedure, see ASC vs HOPD: How Reimbursement Differs for the Most Common Procedures.

The catch is that a newly covered procedure with no commercial rate attached is not a payment, it is a negotiation. A cardiovascular program that adds diagnostic cath or device procedures under the 2026 list without first pricing the case against its own cost structure is negotiating blind.

Office-based lab vs ASC: two different cost structures

The office-based lab vs ASC question comes up in almost every cardiology group considering where to put a new cath suite. The two settings are not substitutes with different paperwork, they carry different cost and payment structures entirely. An OBL is typically owned and staffed more leanly, often by the physician group directly, with lower facility overhead but a narrower set of payable services and, in most states, no Medicare ASC facility fee. An ASC carries higher fixed cost (licensure, accreditation, a broader staffing model) in exchange for a facility fee, a wider covered procedures list after the 2026 expansion, and the ability to bring in cases that an OBL cannot perform under its state scope.

FACTS available publicly do not give a clean head-to-head margin comparison between the two settings for cardiovascular procedures, and the honest answer is that the number varies by state, by payer mix and by whether the physicians already have ASC infrastructure in place through another specialty. What is documented is the facility fee differential between ASC and hospital outpatient settings, and the general direction of Medicare policy toward paying the same rate regardless of site of care. Groups weighing OBL versus ASC should run both settings through the same case costing exercise before committing capital, not after.

What the covered list expansion changed, in numbers

The table below isolates the pieces of the CY2026 rule and related policy that matter most for a cardiovascular program.

CY2026 Medicare rule and related policy affecting cardiovascular ASC economics (CMS, November 2025; AHPA/NCSL, 2025)
ItemWhat it meansSource
Payment updateAbout 2.6% increase for ASC and hospital outpatient rates, contingent on quality reportingCMS, November 2025
Procedures added to covered list560 surgical procedures and 35 ancillary services addedCMS, November 2025
Inpatient-only codes removed271 codes, part of a three-year phase-out starting in 2026CMS, November 2025
ASCQR penalty for non-reportingA missed submission cuts the annual payment update by 2.0 percentage pointsCMS
Certificate of need35 states plus DC still run some form of CON review; several exempt ASCs or apply lighter reviewAHPA/NCSL, 2025
Implant and device carve-outsCommonly negotiated at invoice plus a handling percentage for ortho, spine and cardiology proceduresSigmatic, 2027 ASC State of the Union

The quality reporting line matters more for cardiology than it looks. A new cath or device program adds complexity to a center's reporting burden at the same time it adds revenue. A missed ASCQR submission does not just cost the facility fee on the new procedures, it costs the update on every case the center already does.

Pricing a cardiovascular case correctly

Cardiovascular cases are device and implant heavy, which means the gap between a well-priced case and a poorly priced one is almost entirely in the supply line. The same case costing discipline that works for orthopedics and spine applies here: net revenue by payer, actual device and supply consumption rather than the preference card, labor loaded by minutes in the room, and fixed cost spread by scheduled OR time. The full method is laid out at Case Costing for Surgery Centers, and the supply-side benchmarks by specialty, including how implant-heavy specialties compare to lower-supply-cost cases like GI and ophthalmology, are covered in Supply Cost per Case per Specialty: Orthopedics, GI, Ophthalmology and Spine.

A few things to check before a new cardiovascular procedure goes on the schedule:

  • Price the device and implant cost from the actual invoice, not the vendor's list price, and confirm whether the payer contract carves implants out at invoice plus a handling fee.
  • Confirm the commercial rate exists for the new code. A procedure newly added to the covered list may have a Medicare rate and no negotiated commercial rate at all.
  • Model anesthesia and monitoring staffing against the specific procedure, since cardiovascular cases often carry longer monitored recovery time than the general case mix the center is staffed for.
  • Run the contribution margin by payer before committing block time. A procedure with volume and a negative margin under one payer is not a volume play, it is a contracting problem.

None of this requires new software to start, though the systems a center runs on determine how fast the ten-number scorecard can be pulled each month. A comparison of the EMR, billing and analytics platforms most centers use for this kind of reporting is in ASC Software in 2027: An Honest Comparison of EMR, Billing and Analytics Tools.

Certificate of need, ownership and the capital question

Thirty-five states plus the District of Columbia still run some form of certificate of need review, and a cardiovascular program is often the kind of capital-intensive addition that draws the most scrutiny, since it can be read by a CON board as duplicating hospital cardiac services. Several states exempt ASCs outright or apply lighter review, so the first step for any group adding cardiovascular procedures is confirming the state's current CON posture, not assuming the center's existing certification covers the new service line.

Ownership structure matters just as much as the regulatory path. Physician-owned centers hold about 62 percent of ASC market revenue, and federal safe harbor rules generally require each physician owner to perform a meaningful share of procedures at the center. A cardiology group building out its own ASC, rather than adding cases to an existing multi-specialty center, should weigh that against the option of a hospital joint venture, which trades some ownership and profit share for contracting leverage with payers that already have cardiac networks in place. Management companies brought in to run newly added service lines commonly charge a fee in the range of 4 to 7 percent of net revenue in addition to any equity stake, a cost that belongs in the pro forma from day one, not discovered after the first full year of operation.

What to do this quarter

Three steps for a cardiovascular program weighing ASC or OBL expansion under the 2026 covered list changes:

  1. Cost the top five cardiovascular procedures your physicians already perform in a hospital setting, using actual device invoices and loaded labor minutes, and rank them by contribution margin before adding any to the block schedule.
  2. Confirm your state's certificate of need posture for cardiovascular ASC services specifically, not just the center's general CON status, and get that answer before signing a lease or ordering equipment.
  3. Call the two payers with the highest cardiology volume and ask directly whether a commercial rate exists for each newly covered code. If it does not, that call is the start of the negotiation, not an afterthought once cases are already on the schedule.

Make your ASC more profitable

Sigmatic is a team of ASC consultants who use our own technology to manage surgery centers: better margins, better workflows, and a real-time view of cost per case and utilization that keeps the gains in place. If the numbers in this article look like your center, book a free 30-minute consultation and we will go through your own figures and show you where the margin is. Read the Case Costing for Surgery Centers guide, grab the free PDF, The 2027 ASC State of the Union: maximizing profit on razor-thin margins, from the form on this page, or email [email protected].

Free guide

The 2027 ASC State of the Union: Maximizing profit on razor-thin margins

16 pages of charts: the market, the 2026 reimbursement rules, the benchmarks that separate a 13 percent margin from a 37 percent one, a case costing method you can run this month and a 90-day plan.

One email with the PDF, then the occasional note on ASC margins. Unsubscribe any time.

Before you go

Want a more profitable ASC?

Book a free 30-minute consultation on your own numbers, or leave your email and we will send the 2027 guide first.

Make your ASC more profitable.

A free 30-minute consultation on your own numbers: where the margin is, what to fix first. No obligation.